格列吡嗪雜質(zhì)Ⅰ(4-[2-(5-甲基吡嗪-2-甲酰氨基)乙基]苯磺酰胺 )
|
PCL-#-Chp0359-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
33288-71-0 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列吡嗪雜質(zhì)Ⅰ(4-[2-(5-甲基吡嗪-2-甲酰氨基)乙基]苯磺酰胺 )
|
PCL-#-Chp0359-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
33288-71-0 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列齊特雜質(zhì)Ⅰ〔1-(3-氮雜雙環(huán)[3.3.0]辛基)-3-鄰甲苯磺酰脲〕
|
PCL-#-Chp0358-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
1076198-18-9 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列齊特雜質(zhì)Ⅰ〔1-(3-氮雜雙環(huán)[3.3.0]辛基)-3-鄰甲苯磺酰脲〕
|
PCL-#-Chp0358-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
1076198-18-9 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列本脲雜質(zhì)Ⅱ(N-(4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰氨基-甲酸乙酯))
|
PCL-#-Chp0357-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
14511-59-2 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列本脲雜質(zhì)Ⅱ(N-(4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰氨基-甲酸乙酯))
|
PCL-#-Chp0357-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
14511-59-2 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列本脲雜質(zhì)Ⅰ(4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺)
|
PCL-#-Chp0356-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
16673-34-0 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
格列本脲雜質(zhì)Ⅰ(4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺)
|
PCL-#-Chp0356-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
16673-34-0 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸賽洛唑啉雜質(zhì)Ⅰ(N-(2-氨乙基)-2-[4-(1,1-二甲基乙基)-2,6-二甲基苯基]乙酰胺)
|
PCL-#-Chp0355-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
94266-17-8 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸賽洛唑啉雜質(zhì)Ⅰ(N-(2-氨乙基)-2-[4-(1,1-二甲基乙基)-2,6-二甲基苯基]乙酰胺)
|
PCL-#-Chp0355-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
94266-17-8 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸賽庚啶雜質(zhì)Ⅰ(1-甲基-4-(5H-二苯并[a,d]環(huán)庚三烯-5-羥基)哌啶 )
|
PCL-#-Chp0354-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3967-32-6 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸賽庚啶雜質(zhì)Ⅰ(1-甲基-4-(5H-二苯并[a,d]環(huán)庚三烯-5-羥基)哌啶 )
|
PCL-#-Chp0354-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3967-32-6 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸溴己新雜質(zhì)Ⅰ(N-甲基-N-環(huán)己基-2-氨基-5-氯-3-溴苯甲胺)
|
PCL-#-Chp0353-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
32193-43-4 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸溴己新雜質(zhì)Ⅰ(N-甲基-N-環(huán)己基-2-氨基-5-氯-3-溴苯甲胺)
|
PCL-#-Chp0353-30mg
|
≥95% 雜質(zhì)對(duì)照品 |
32193-43-4 |
30mg
|
¥ 1480.0
|
現(xiàn)貨 |
PCL |
鹽酸雷尼替丁雜質(zhì)Ⅰ(N-[2-[[5-[(二甲基氨基)甲基]呋喃-2-基]甲基]硫基]乙基]-2-硝基乙酰胺)
|
PCL-#-Chp0352-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
117846-02-3 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸雷尼替丁雜質(zhì)Ⅰ(N-[2-[[5-[(二甲基氨基)甲基]呋喃-2-基]甲基]硫基]乙基]-2-硝基乙酰胺)
|
PCL-#-Chp0352-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
117846-02-3 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸瑞芬太尼雜質(zhì)Ⅱ(4-(甲氧甲?;?4-(N-苯基-N-丙酰氨基)-1-哌啶)
|
PCL-#-Chp0351-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0351-N/A |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸瑞芬太尼雜質(zhì)Ⅱ(4-(甲氧甲?;?4-(N-苯基-N-丙酰氨基)-1-哌啶)
|
PCL-#-Chp0351-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0351-N/A |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸瑞芬太尼雜質(zhì)Ⅰ(4-(甲氧甲?;?4-(N-苯基-N-丙酰氨基)-1-哌啶丙酸)
|
PCL-#-Chp0350-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0350-N/A |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸瑞芬太尼雜質(zhì)Ⅰ(4-(甲氧甲酰基)-4-(N-苯基-N-丙酰氨基)-1-哌啶丙酸)
|
PCL-#-Chp0350-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0350-N/A |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸喹那普利雜質(zhì)Ⅰ [3S-[2(R* ),3α,11αβ]]-1,3,4,6,11,11α-六氫-3-甲基-1,4-二氧代-α-(2-苯乙基)-2H-吡嗪并[1,2-b]異喹啉-2-乙酸乙酯
|
PCL-#-Chp0349-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
103733-49-9 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸喹那普利雜質(zhì)Ⅰ [3S-[2(R* ),3α,11αβ]]-1,3,4,6,11,11α-六氫-3-甲基-1,4-二氧代-α-(2-苯乙基)-2H-吡嗪并[1,2-b]異喹啉-2-乙酸乙酯
|
PCL-#-Chp0349-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
103733-49-9 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸硫必利雜質(zhì)Ⅰ(硫必利氮氧化物)
|
PCL-#-Chp0348-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
63484-11-7 |
50mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |
鹽酸硫必利雜質(zhì)Ⅰ(硫必利氮氧化物)
|
PCL-#-Chp0348-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
63484-11-7 |
25mg
|
咨詢(xún)
|
咨詢(xún) |
PCL |